Henry Schein (HSIC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
The chairman welcomed stockholders to the 31st annual meeting, conducted virtually, and outlined meeting procedures and rules of conduct.
Board and executive committee updates
Introduction of current directors, including independent directors and new CEO Fred Lowery, who joined the board in March 2026.
Recognition of outgoing board members for their years of service and leadership, including the chairman stepping down after 44 years.
Announcement that a new non-executive chair will be selected following the meeting.
Corporate governance
Shareholder proposal to eliminate supermajority voting requirements in favor of majority vote was presented and discussed.
The board recommended voting against the proposal, but it was ultimately approved by shareholders.
Latest events from Henry Schein
- Global leader in dental and medical products with $13.2B sales and strong growth momentum.HSIC
Corporate presentation - Q2 2026 saw strong sales, margin, and EPS growth, prompting a raised FY2026 outlook.HSIC
Q2 2026 - Strategic initiatives and value creation projects drive stable growth and operational efficiency.HSIC
Baird Global Healthcare Conference 2025 - Transformation, innovation, and disciplined growth drive strong outlook and value creation.HSIC
Stifel Jaws & Paws Conference 2026 - Strong Q1 growth, margin expansion, and strategic focus position the company for 2026 targets.HSIC
Bank of America Global Healthcare Conference 2026 - Board urges support for director nominees and opposes majority vote proposal at annual meeting.HSIC
Proxy filing - Record Q3 2025 results, raised guidance, and $200M+ value creation initiatives announced.HSIC
Q3 2025 - Q2 2024 sales up 1.1% to $3.14B; net income and EPS declined, and guidance was reduced.HSIC
Q2 2024 - Q4 2024 non-GAAP EPS rose 80% on 5.8% sales growth; 2025 outlook targets steady gains.HSIC
Q4 2024